1. Home
  2. CRF vs SDGR Comparison

CRF vs SDGR Comparison

Compare CRF & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cornerstone Total Return Fund Inc. (The)

CRF

Cornerstone Total Return Fund Inc. (The)

HOLD

Current Price

$6.43

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

SDGR

Schrodinger Inc.

HOLD

Current Price

$19.47

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRF
SDGR
Founded
N/A
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
CRF
SDGR
Price
$6.43
$19.47
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$21.00
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
N/A
N/A
Revenue
N/A
$255,869,000.00
Revenue This Year
N/A
$0.76
Revenue Next Year
N/A
$4.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.29
52 Week Low
$6.44
$10.95
52 Week High
$8.25
$23.02

Technical Indicators

Market Signals
Indicator
CRF
SDGR
Relative Strength Index (RSI) 26.00 64.89
Support Level N/A $17.23
Resistance Level $7.31 N/A
Average True Range (ATR) 0.09 0.86
MACD -0.06 0.14
Stochastic Oscillator 4.17 78.31

Price Performance

Historical Comparison
CRF
SDGR

About CRF Cornerstone Total Return Fund Inc. (The)

Cornerstone Total Return Fund Inc is a diversified closed-end management company. Its objective is to seek capital appreciation with current income as a secondary objective. The company invests in sectors such as Information Technology, Health Care, Financials, Communication Services, Consumer Discretionary, Industrials, Exchange-Traded Funds, Utilities, Energy, Real Estate, and others.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: